Back to UBS Group AG UBS Group AG

AUTLAUTL
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in AUTOLUS THERAPEUTICS LTD

UBS Group AG holds 1.5M shares of AUTL (AUTOLUS THERAPEUTICS LTD), worth $2.4M as of 2026-Q2. The position was increased (+16.2% shares). AUTL represents 0.0% of UBS Group AG's portfolio.

Current Value

$2.4M

Current Shares

1.5M

Total Value Change

+$1.9M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+16.2%
$2.4M0.0%$1.60
30
2026-Q1
Increased
1.3M
+48.9%
$1.8M0.0%$1.62
35
2025-Q4
Increased
877,100
+113.6%
$1.7M0.0%$1.97
42
2025-Q3
Increased
410,662
+16.1%
$669,3780.0%$1.59
28
2025-Q2
Increased
353,667
+11.8%
$806,3610.0%$2.31
28
2025-Q1
Increased
316,227
+57.9%
$490,1520.0%$1.66
34
2024-Q4
Increased
200,232
+27.6%
$470,5450.0%$2.21
30
2024-Q3
Increased
156,978
+15.6%
$569,8300.0%$3.63
28

Other major holders of AUTL: Blackstone Inc., WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used